Stay updated on Cabozantinib in Advanced Penile Squamous Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Advanced Penile Squamous Cell Carcinoma Clinical Trial page.

Latest updates to the Cabozantinib in Advanced Penile Squamous Cell Carcinoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedNew page revision tag v3.5.0 was added. The previous revision tag v3.4.3 was removed.SummaryDifference0.1%

- Check25 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This is a background version-label change that does not affect study details or user workflows.SummaryDifference0.1%

- Check54 days agoChange DetectedA new site revision label `Revision: v3.4.2` has been added. The previously displayed government funding status notice (lapse in funding) has been removed.SummaryDifference0.4%

- Check61 days agoChange DetectedA site-wide notice regarding government funding and a revision update from v3.4.0 to v3.4.1 were added. No study content, eligibility criteria, or results were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check69 days agoChange DetectedUI/metadata changes include showing a glossary, adding Last Update Submitted that Met QC Criteria, adding No FEAR Act Data, and Revision: v3.4.0, while removing the older QC label and Revision: v3.3.4. These updates do not affect core trial details such as title, conditions, endpoints, eligibility criteria, locations, or study results.SummaryDifference0.2%

- Check83 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page. This is a minor maintenance update with no changes to the page's core content or study information.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib in Advanced Penile Squamous Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Advanced Penile Squamous Cell Carcinoma Clinical Trial page.